Allergan’s Nasal Spray For Frequent Nighttime Urination Gets Cautious Panel Nod

Desmopressin's limited efficacy over placebo doesn't dissuade FDA's advisory committee, which votes 14 to 4 in favor of approval even as many suggest indication be narrowed.